EUVIMEDEUVIMED entdecken
Crossref

Oroxylin-A Attenuates Taurocholate-Induced Lung Injury via NF-κB Pathway Suppression

Houhong Wang, Zaibiao Wang

Clinical and Molecular Epidemiology · 2025

DOI: 10.53964/cme.2025005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Epidemiology, 2025. Verfasst von Houhong Wang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Acute pancreatitis (AP)-related acute lung injury (ALI) remains a significant clinical challenge. This study evaluated the protective effects of oroxylin A (OroA), a flavonoid compound, on AP-associated pulmonary inflammation and injury.

Methods

Rats were randomized into sham, AP (sodium taurocholate 1mg/kg, iv), and AP+OroA (10/20/30mg/kg, ip) groups. OroA was administered 30 minutes prior to taurocholate challenge. Animals were euthanized at 3, 6, 12, and 24 hours post-treatment. Pulmonary function, inflammatory markers, and histological changes were analyzed.

Results

Taurocholate induced significant hypoxemia (PaO₂↓32%), pulmonary edema (W/D ratio↑80%), and inflammation (MPO↑210%, NO↑180%, HMGB1↑350%). OroA pretreatment dose-dependently reversed these alterations (P

Zitieren

APA

Wang, H., & Wang, Z. (2025). Oroxylin-A Attenuates Taurocholate-Induced Lung Injury via NF-κB Pathway Suppression. Clinical and Molecular Epidemiology. https://doi.org/10.53964/cme.2025005

Vancouver

Wang H, Wang Z. Oroxylin-A Attenuates Taurocholate-Induced Lung Injury via NF-κB Pathway Suppression. Clinical and Molecular Epidemiology. 2025. doi:10.53964/cme.2025005

BibTeX
@article{Wang2025,
  author = {Wang, Houhong and Wang, Zaibiao},
  title = {Oroxylin-A Attenuates Taurocholate-Induced Lung Injury via NF-κB Pathway Suppression},
  journal = {Clinical and Molecular Epidemiology},
  year = {2025},
  doi = {10.53964/cme.2025005}
}
Kostenlos starten →